| Code | 3983B | ||||||||||
| MA number | 42/0154/15-S | ||||||||||
| Product Form: | sol inf 5x100 ml/500 mg (liek.inj.skl.) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | KRKA, d.d., Novo mesto, Slovenia | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 22.04.2015 |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_Levalox 5 mg-ml infúzny roztok_02_2025.pdf
|
| SPC: |
SPC_Levalox 5 mg-ml infúzny roztok_02_2025.pdf
|
| Safety feature | Yes |
| Data update: | 30.12.2019 |
